DOI QR코드

DOI QR Code

Assessment of Chronic Toxicity of an Ayurvedic Herbo-Metallic Formulation Rasaraj Rasa in Wistar Rats

  • Chaitali S., Waghmare (Shree Dhootapapeshwar Ayurvedic Research Foundation) ;
  • Shivcharan R., Bidve (Shree Dhootapapeshwar Ayurvedic Research Foundation) ;
  • Ramacharya V., Gudi (Shree Dhootapapeshwar Limited) ;
  • Megha L., Nalawade (Shree Dhootapapeshwar Limited) ;
  • Mukesh B., Chawda (Solumiks Herbaceutical Limited)
  • Received : 2022.05.16
  • Accepted : 2022.09.15
  • Published : 2022.12.30

Abstract

Objectives: This study aimed to assess the adverse effects of Rasaraj Rasa tablets after repeated oral administration for 180 days in Wistar rats. Methods: Wistar rats were divided into five groups, of which three were treated with 54, 162, and 270 mg/kg body weight of Rasaraj Rasa, respectively, which correspond to one, three, and five times the proposed human therapeutic dose, for 180 days consecutively. The fifth group (satellite) also received 270 mg/kg body weight of Rasaraj Rasa for 180 days. Body weight and food intake were measured weekly. At the end of the study, all rats were sacrificed, and their blood, serum, and organs were collected and examined using hematology, serum biochemistry, gross pathology, and histopathology tests. In contrast, the satellite group was kept for 4 weeks after treatment. Results: No significant treatment-related toxicological findings were observed in the clinical features, body weight, laboratory findings, and pathological findings of the high-dose treated groups, when compared to those of the control group. Conclusion: The no-observed-adverse-effect-level for Rasaraj Rasa in Wistar rats is set at 270 mg/kg body weight.

Keywords

Acknowledgement

The research was funded by Shree Dhootapapeshwar Limited, Mumbai, India.

References

  1. Chauhan A, Semwal DK, Mishra SP, Semwal RB. Ayurvedic research and methodology: present status and future strategies. Ayu. 2015;36(4):364-9.  https://doi.org/10.4103/0974-8520.190699
  2. Singh SK, Chaudhary A, Rai DK, Rai SB. Preparation and characterization of a mercury based Indian traditional drug RasSindoor. Indian J Tradit Knowl. 2009;8(3):346-51. 
  3. Wang Q, Yang X, Zhang B, Yang X, Wang K. The anxiolytic effect of cinnabar involves changes of serotonin levels. Eur J Pharmacol. 2007;565(1-3):132-7.  https://doi.org/10.1016/j.ejphar.2007.03.018
  4. Galib, Barve M, Mashru M, Jagtap C, Patgiri BJ, Prajapati PK. Therapeutic potentials of metals in ancient India: a review through Charaka Samhita. J Ayurveda Integr Med. 2011;2(2):55-63.  https://doi.org/10.4103/0975-9476.82523
  5. Albers JW, Kallenbach LR, Fine LJ, Langolf GD, Wolfe RA, Donofrio PD, et al. Neurological abnormalities associated with remote occupational elemental mercury exposure. Ann Neurol. 1988;24(5):651-9.  https://doi.org/10.1002/ana.410240510
  6. Chuu JJ, Liu SH, Lin-Shiau SY. Differential neurotoxic effects of methylmercury and mercuric sulfide in rats. Toxicol Lett. 2007;169(2):109-20.  https://doi.org/10.1016/j.toxlet.2006.12.006
  7. Paul S, Chugh A. Assessing the role of Ayurvedic 'Bhasms' as ethno-nanomedicine in the metal based nanomedicine patent regime. J Intell Prop Rights. 2011;16:509-15. 
  8. Saper RB, Phillips RS, Sehgal A, Khouri N, Davis RB, Paquin J, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-23.  https://doi.org/10.1001/jama.300.8.915
  9. Kumar A, Nair AG, Reddy AV, Garg AN. Bhasmas: unique ayurvedic metallic-herbal preparations, chemical characterization. Biol Trace Elem Res. 2006;109(3):231-54.  https://doi.org/10.1385/BTER:109:3:231
  10. Payyappallimana U, Venkatasubramanian P. Exploring ayurvedic knowledge on food and health for providing innovative solutions to contemporary healthcare. Front Public Health. 2016;4:57. 
  11. Kamath SU, Pemiah B, Sekar RK, Krishnaswamy S, Sethuraman S, Krishnan UM. Mercury-based traditional herbo-metallic preparations: a toxicological perspective. Arch Toxicol. 2012;86(6):831-8.  https://doi.org/10.1007/s00204-012-0826-2
  12. OECD. Test no.452: OECD guideline for the testing of chemicals: chronic toxicity studies. Paris: OECD Publication; 2009. 
  13. Burtis CA, Ashwood ER, Tietz NW. Tietz textbook of clinical chemistry. 3rd ed. Philadelphia: W.B. Saunders; 1999. p. 652, 1136. 
  14. Oberoi K, Tatke P. Piperine enhances the bioavailability of secnidazole in rats. MOJ Bioequivalence Bioavailab. 2017;3(3):76-81. 
  15. Gokarn RA, Nariya MB, Patgiri BJ, Prajapati PK. Toxicological studies of Rasasindura, an Ayurvedic formulation. Indian J Pharm Sci. 2017;79(4):633-40. 
  16. Joshi N, Dash MK, Dwivedi L, Khilnani GD. Toxicity study of Lauha Bhasma (calcined iron) in albino rats. Anc Sci Life. 2016;35(3):159-66.  https://doi.org/10.4103/0257-7941.179870
  17. Prabu PC, Panchapakesan S, Raj CD. Acute and sub-acute oral toxicity assessment of the hydroalcoholic extract of Withania somnifera roots in Wistar rats. Phytother Res. 2013;27(8):1169-78.  https://doi.org/10.1002/ptr.4854
  18. Jamadagni PS, Jamadagni SB, Singh R, Gaidhani SN, Upadhyay S, Hazra J. Repeated dose oral toxicity of Trivanga Bhasma in Swiss albino mice. Ayu. 2013;34(1):118-23.  https://doi.org/10.4103/0974-8520.115449
  19. Mitra A, Chakraborty S, Auddy B, Tripathi P, Sen S, Saha AV, et al. Evaluation of chemical constituents and free-radical scavenging activity of Swarnabhasma (gold ash), an ayurvedic drug. J Ethnopharmacol. 2002;80(2-3):147-53.  https://doi.org/10.1016/S0378-8741(02)00008-9
  20. Timbrell JA. Principles of biochemical toxicology. London: Taylor and Francis; 1982. 
  21. Boorman GA, Eustis SL, Elwell MR, Montgomery CA, MacKenzie WF. Pathology of the Fischer rat: reference and atlas. London: Academic Press; 1990. 
  22. Greaves P. Histopathology of preclinical toxicity studies. 3rd ed. New York: Elsevier; 2007. p. 466, 577-8. 
  23. Pearse G. Histopathology of the thymus. Toxicol Pathol. 2006;34(5):515-47.  https://doi.org/10.1080/01926230600978458
  24. Vos JG, Kimber I, Kuper CF, van Loveren H, Schuurman HJ. The immune system. In: Turton J, Hooson J, editors. Target organ pathology: a basic text. London: Taylor and Francis; 1998. p. 207-37. 
  25. Chandramouli R, Thirunarayanan T, Mukeshbabu K, Sriram R. Designing toxicological evaluation of Ayurveda and Siddha products to cater to global compliance - current practical and regulatory perspective. J Pharm Sci Res. 2010;2(12):867-77. 
  26. Saad B, Azaizeh H, Abu-Hijleh G, Said O. Safety of traditional arab herbal medicine. Evid Based Complement Alternat Med. 2006;3(4):433-9. https://doi.org/10.1093/ecam/nel058